PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
Public ClinicalTrials.gov record NCT00269620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Randomized, Multicenter Trial to Evaluate Continuation Rates, Side Effects and Acceptability of NuvaRing Versus OrthoEvra
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label prospective, multicenter, randomized trial to compare continuation rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred women will be recruited at 9 centers nationwide to be randomly assigned to use either the NuvaRing or OrthoEvra for four months. Women must either be on the pill or have recently stopped the pill and be relatively satisfied with oral contraceptive use to qualify for enrollment. Two visits and two phone calls will be required.
Study identification
- NCT ID
- NCT00269620
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Interventions
- ethinyl estradiol/etonogestrel vaginal ring Drug
- ethinyl estradiol/norelgestromin transdermal contraceptive Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2005
- Primary completion
- Nov 30, 2006
- Completion
- Nov 30, 2006
- Last update posted
- Oct 20, 2008
2005 – 2006
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA-Harbor | Los Angeles | California | — | — |
| University of Chicago | Chicago | Illinois | — | — |
| Johns Hopkins | Baltimore | Maryland | — | — |
| Boston University | Boston | Massachusetts | — | — |
| Columbia University | New York | New York | — | — |
| Oregon Health Science University | Portland | Oregon | — | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | — | — |
| Magee-Womens Hospital | Pittsburgh | Pennsylvania | 15213 | — |
| Eastern Virginia Medical School | Norfolk | Virginia | — | — |
| University of Wisconsin | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00269620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2008 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00269620 live on ClinicalTrials.gov.